The spectrum of pituitary growth hormone responses to pharmacological stimuli in acromegaly.

No abstract is available for this paper.

• Publication year

  1980

• Venue

  Journal of Clinical Endocrinology and Metabolism

• Publication date

  1980-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/JCEM-51-2-292PMID 6772662
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Selective total removal of a growth-hormone-secreting adenoma: evidence that acromegaly is a primary pituitary disease.

  1979cited by this paper
• EVALUATION OF THE RESULTS OF TRANS‐SPHENOIDAL SURGERY IN ACROMEGALY BY ASSESSMENT OF THE GROWTH HORMONE RESPONSE TO THYROTROPHIN‐RELEASING HORMONE

  1978cited by this paper
• Neural regulation of growth hormone secretion.

  1978cited by this paper
• Adenylate cyclase of GH and ACTH producing tumors of human: activation by non-specific hormones and other bioactive substances.

  1977cited by this paper
• Neurotransmitters and Anterior Pituitary Function

  1977cited by this paper
• Abnormal growth hormone responses to L-dopa and thyrotropin-releasing hormone in patients with acromegaly.

  1977cited by this paper
• Long-term treatment of acromegaly with bromocriptine.

  1977cited by this paper
• Long-term treatment with 2-Br-alpha-ergocryptine in acromegaly.

  1977cited by this paper
• Failure of growth hormone-suppressing agents to affect TSH-releasing hormone- and LH-releasing hormone-induced growth hormone release in acromegaly.

  1977cited by this paper
• Inhibitory action of somatostatin on pancreatic alpha and beta cell function.

  1975cited by this paper
• Inhibitory Action of Somatostatin on Pancreatic α and β Cell Function1

  1975cited by this paper
• Recovery from paradoxical growth hormone responses in acromegaly after transphenoidal selective adenomectomy.

  1975cited by this paper
• Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin.

  1975cited by this paper
• Inhibition of adenosine 3',5'-monophosphate accumulation in anterior pituitary gland in vitro by growth hormone-release inhibiting hormone.

  1974cited by this paper
• Adrenergic modulation of growth hormone secretion in acromegaly: suppression during phentolamine and phentolamine-isoproterenol administration.

  1974cited by this paper
• Growth Hormone Release Inhibiting Hormone in Acromegaly

  1974cited by this paper
• Decreased plasma growth hormone (GH) levels in acromegalics following CB 154(2-Br-alpha ergocryptine) administration.

  1974cited by this paper
• DECREASED PLASMA GROWTH HORMONE (GH) LEVELS IN ACROMEGALICS FOLLOWING CB 154(2-Br-α-ERGOCRYPTINE) ADMINISTRATION1

  1974cited by this paper
• Suppressibility of plasma growth hormone levels in acromegaly with dexamethasone and phentolamine.

  1973cited by this paper
• Chlorpromazine treatment and growth hormone secretory responses in acromegaly.

  1973cited by this paper
• Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone

  1973cited by this paper
• Inhibition of growth hormone release in humans by somatostatin.

  1973cited by this paper
• Stimulation of growth hormone by luteinizing hormone-releasing hormone in active acromegaly.

  1973cited by this paper
• Neural regulation of growth hormone secretion.

  1973cited by this paper
• A survey of growth hormone secretion and action.

  1973cited by this paper
• Inhibitory effect of L-Dopa on GH release in acromegalic patients.

  1972cited by this paper
• Increase of serum growth hormone concentration following thyrotropin-releasing hormone injection in patients with acromegaly or gigantism.

  1972cited by this paper
• Galactorrhoea: Successful Treatment with Reduction of Plasma Prolactin Levels by Brom-ergocryptine

  1972cited by this paper
• In vitro release of monkey pituitary growth hormone by acromegalic plasma.

  1971cited by this paper
• Acromegaly treated with chlorpromazine. A case study.

  1971cited by this paper
• Nervous system participation in growth hormone release from anterior pituitary gland.

  1971cited by this paper
• Growth hormone dynamics in acromegaly.

  1970cited by this paper
• Progestins in the medical management of active acromegaly.

  1970cited by this paper
• Regulation of growth hormone secretion in acromegaly.

  1969cited by this paper
• THE EFFECTS OF GROWTH HORMONE ON CARBOHYDRATE AND LIPID METABOLISM IN THE DOG *

  1968cited by this paper
• Serum human growth hormone (HGH) response to IV glucose: diagnosis of acromegaly in females and males.

  1968cited by this paper
• Acute effects of human growth hormone on insulin secretion and glucose utilization in normal and growth hormone deficient subjects.

  1967cited by this paper
• Correlative studies of growth hormone and insulin plasma concentrations with metabolic abnormalities in acromegaly.

  1965cited by this paper
• A Sensitive Double Antibody Immunoassay for Human Growth Hormone in Plasma

  1964cited by this paper
• The volume of the sella turcica.

  1962cited by this paper

• Multiple aberrant hormone receptors in Cushing's syndrome.

  2015cites this paper
• Chapter 146 – Hormonal Changes and Endocrine Testing in Pregnancy

  2015cites this paper
• Investigation of Responsiveness to Thyrotropin-Releasing Hormone in Growth Hormone-Producing Pituitary Adenomas

  2013influential citation
• Effect of a somatostatin analogue on trophic hormone levels in acromegalic patients with elevated hGH after adenomectomy and treatment with bromocriptine.

  2009cites this paper
• Biochemical Evaluation of Patients with Active Acromegaly and Type 2 Diabetes Mellitus: Efficacy and Safety of the Galanin Test

  2008cites this paper
• The Dopaminergic Growth Hormone Subjects Regulation Secretion in of Plasma Normal

  2006cites this paper
• Factors Determining in the Treatment of the Effectiveness of CB-154 Acromegaly

  2006cites this paper
• Development of acromegaly in a patient with anorexia nervosa: Pathogenetic and diagnostic implications

  2006cites this paper
• Evidence for Endogenous of GH Release in Man Dopaminergic Control KUNIHIKO HANEW

  2006cites this paper
• Usefulness of the thyrotropin-releasing hormone test in pre-clinical acromegaly.

  2005influential citation
• Utilidad de los tests de estimulación para predecir la respuesta a los análogos de la somatostatina en la acromegalia

  2002influential citation
• Postoperative persistent thyrotrophin releasing hormone‐induced growth hormone release predicts recurrence in patients with acromegaly

  2002cites this paper
• Effect of acute elevation of IGF-I on circulating GH, TSH, insulin, IGF-II and IGFBP-3 levels in non-endocrine short stature (NESS)

  2001cites this paper
• Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome.

  2001cites this paper
• Acromegalia com níveis séricos basais do hormônio do crescimento dentro dos limites da normalidade

  2000cites this paper
• Growth hormone response to thyrotrophin releasing hormone in women with polycystic ovarian syndrome.

  1999cites this paper
• Pituitary diseases in pregnancy.

  1998cites this paper
• Hypothalamic dysfunction in "cured" acromegaly is treatment modality dependent.

  1998cites this paper
• Growth hormone response to the hypothalamic somatostatinergic activity in acromegalic patients.

  1997cites this paper
• Characteristics of acromegalic patients with a good response to octreotide, a somatostatin analogue

  1995cites this paper
• Effect of Pyridostigmine on the Hydrocortisone-Mediated Decrease of Circulating Growth Hormone Levels in Acromegaly

  1994cites this paper
• Effect of corticotrophin-releasing hormone administration on growth hormone levels in acromegaly: in vivo and in vitro studies.

  1994cites this paper
• Effect of pyridostigmine on the hydrocortisone-mediated decrease of circulating growth hormone levels in acromegaly.

  1994cites this paper
• Enhanced GH responses to combined administration of GHRP and GHRH in patients with acromegaly.

  1994cites this paper
• Arginine blocks the inhibitory effect of hydrocortisone on circulating growth hormone levels in patients with acromegaly.

  1993cites this paper
• Octreotide and related somatostatin analogs in the diagnosis and treatment of pituitary disease and somatostatin receptor scintigraphy.

  1993cites this paper
• Growth hormone response to thyrotropin-releasing hormone in acromegalic patients: reproducibility and dose-response study.

  1992cites this paper
• The sensitivity of growth hormone secretion to medical treatment in acromegalic patients: influence of age and sex

  1992cites this paper
• Evaluation of GH paradoxical responses to TRH and LHRH in acromegalic patients during long-term treatment with octreotide.

  1992cites this paper
• Differences in pathological findings and growth hormone responses in patients with growth hormone-producing pituitary adenoma.

  1992cites this paper
• Regulation of hormonal secretion in primary cell cultures of human somatotrophinomas

  1992cites this paper
• Resistance to somatostatin (SRIH) analog therapy in acromegaly. Re-evaluation of the correlation between the SRIH receptor status of the pituitary tumor and the in vivo inhibition of GH secretion in response to SRIH analog.

  1992cites this paper
• Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly — The effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone

  1992cites this paper
• Thyrotrophin‐Releasing Hormone Raises Cytosolic Free Calcium Concentration in Human Adenomatous Somatotrophs and Corticotrophs; Comparison with in vivo Responsiveness to Thyrotrophin‐Releasing Hormone in Patients with Acromegaly or Cushing's Disease

  1991cites this paper
• [A case of fibrous dysplasia (McCune Albright syndrome) associated with acromegaly].

  1991cites this paper
• Sensitive Time-ResolvedFluorescenceImmunoassayof Somatotropinin Serum

  1990cites this paper
• Sensitive time-resolved fluorescence immunoassay of somatotropin in serum.

  1990cites this paper
• Differential Response to Aminergic Stimuli and Biological Behavior of Growth Hormone Secreting Pituitary Adenomas

  1990cites this paper
• Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy.

  1990cites this paper
• The growth hormone responses to octreotide in acromegaly correlate with adenoma somatostatin receptor status.

  1989cites this paper
• Octreotide

  1989cites this paper
• Paradoxical growth hormone response following thyroid-stimulating hormone administration in the polycystic ovary syndrome.

  1989cites this paper
• Medical therapy of glycoprotein hormone-secreting pituitary tumors.

  1989cites this paper
• The combination therapy with bromocriptine and cyproheptadine in patients with acromegaly.

  1989cites this paper
• Correlation Between Preoperative Testing and Tumour Morphology in Acromegaly

  1988cites this paper
• Comparison of the sensitivity of growth hormone secretion to somatostatin in vivo and in vitro in acromegaly.

  1988cites this paper
• The role of somatostatin in the regulation of anterior pituitary hormone secretion and the use of its analogs in the treatment of human pituitary tumors.

  1988cites this paper
• The spectrum of GH responses to GHRH and somatostatin in patients with acromegaly.

  1988cites this paper
• GROWTH HORMONE RELEASING FACTOR STIMULATES and SOMATOSTATIN INHIBITS PROLACTIN RELEASE FROM HUMAN MIXED SOMATOTROPH‐LACTOTROPH ADENOMAS IN PERIFUSION

  1987cites this paper
• Somatostatin and the Syndrome of Acromegaly

  1987cites this paper
• Growth hormone responses to the releasing hormones GHRH and GnRH and the inhibitors somatostatin and bromocriptine in TRH-responsive and non-responsive acromegalics.

  1987cites this paper
• Growth hormone inhibitory and stimulatory actions of L-dopa in patients with acromegaly.

  1987cites this paper
• ACROMEGALY

  1987cites this paper
• Growth Hormone Secretion in Acromegaly

  1987cites this paper
• Acromegaly and Gigantism

  1987cites this paper
• McCune-Albright syndrome with gigantism and hyperprolactinemia

  1987cites this paper
• Visualization of somatostatin receptors and correlation with immunoreactive growth hormone and prolactin in human pituitary adenomas: evidence for different tumor subclasses.

  1987cites this paper
• The GH-releasing hormone (GHRH) test in acromegaly before and after adenomectomy

  1987cites this paper
• The Effect of Long Acting Somatostatin Analogue SMS 201-995 in Acromegaly

  1987cites this paper
• Medroxy-progesterone acetate administration to ovariohysterectomized, oestradiol-primed beagle bitches. Effect on secretion of growth hormone, prolactin and cortisol.

  1987cites this paper
• A comparison among the growth hormone-lowering effects in acromegaly of the somatostatin analog SMS 201-995, bromocriptine, and the combination of both drugs.

  1986cites this paper
• Somatostatin in the central nervous system: physiology and pathological modifications.

  1986cites this paper
• Plasma growth hormone responses to somatostatin (SRIH) and SRIH receptors in pituitary adenomas in acromegalic patients.

  1986cites this paper
• The dopaminergic regulation of plasma growth hormone secretion in normal subjects.

  1986cites this paper
• Growth Hormone Hypersecretory States

  1986cites this paper
• Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly.

  1986cites this paper
• The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients.

  1985cites this paper
• Comparative study on the responses of plasma GH to synthetic GH-releasing factor and other stimulatory and inhibitory agents in patients with acromegaly.

  1985cites this paper
• Modulation of postinhibitory increase in plasma prolactin by domperidone in patients with prolactin secreting adenoma.

  1985cites this paper
• Specific somatostatin receptors on human pituitary adenoma cell membranes.

  1985cites this paper
• Somatostatin receptors in human growth hormone and prolactin-secreting pituitary adenomas.

  1985cites this paper
• [Hormonal evaluation of 27 patients with acromegaly].

  1985cites this paper
• Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.

  1985cites this paper
• Prolactin and Growth Hormone in Health and Disease

  1985cites this paper
• High density of somatostatin receptors in pituitary tumors from acromegalic patients.

  1984cites this paper
• The mechanism of postinhibitory rebound increases in plasma gh in acromegalic patients.

  1984cites this paper
• Somatostatinoma syndrome accompanied by overproduction of pancreatic polypeptide.

  1984cites this paper
• The interrelationship between the effects of somatostatin and human pancreatic growth hormone-releasing factor on growth hormone release by cultured pituitary tumor cells from patients with acromegaly.

  1984cites this paper
• Plasma growth hormone responses to sulpiride in patients with acromegaly.

  1984cites this paper
• The growth hormone responses to L-dopa and TRH in acromegaly

  1984cites this paper
• Comparison of growth hormone responses to human pancreatic growth hormone releasing factor and other pharmacological stimuli in acromegalic patients.

  1984cites this paper
• Effect of synthetic ovine corticotropin-releasing factor on growth hormone secretion in patients with acromegaly.

  1984cites this paper
• Modulation of postinhibitory rebound rise in plasma GH by hypothalamic hormones in patients with acromegaly.

  1984cites this paper
• Nonspecific Pituitary Responses to Hypothalamic Hormones in Basic and Clinical Research

  1984cites this paper
• Pituitary tumors: Diagnosis and therapy

  1983cites this paper
• Factors determining the effectiveness of CB-154 in the treatment of acromegaly.

  1983cites this paper
• Recent Developments in Acromegaly: A Review1

  1983cites this paper
• Somatostatinoma syndrome の一例

  1983cites this paper
• [Comparison of various treatments for tumoral acromegaly. Study of initial prognostic factors].

  1983cites this paper
• CRITICAL STUDY OF THE GROWTH HORMONE RESPONSE TO DYNAMIC TESTS AND THE INSULIN GROWTH FACTOR ASSAY IN ACROMEGALY AFTER MICROSURGERY

  1983cites this paper
• The glucagonoma syndrome.

  1982cites this paper
• Somatostatin sensitivity and growth hormone responses to releasing hormones and bromocryptine in acromegaly.

  1982cites this paper
• [Post-therapeutic hormonal surveillance of somatotropic adenoma].

  1982cites this paper
• The autonomy of prolactin secretion in patients with prolactin producing tumor.

  1982cites this paper
• Paradoxical responses to releasing hormones

  1982influential citation
• [Dopamine and pituitary hormones. Physiology and pathology (author's transl)].

  1981cites this paper
• Evidence for endogenous dopaminergic control of GH release in man.

  1981cites this paper
• Multiple forms of growth hormone: detection in medium from cultured pituitary adenoma explants.

  1981cites this paper